Dexmedetomidine, which is a relatively selective alpha2-adrenoceptor agonist, is used for sedation and analgesia in intensive care unit patients, during awake craniotomies in pediatric and adult patients, and during magnetic resonance imaging, with minimal depression of respiratory function. The successful use of dexmedetomidine in a pediatric patient undergoing bilateral deep brain stimulator placement for the treatment of generalized dystonia, is presented.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jclinane.2008.06.038DOI Listing

Publication Analysis

Top Keywords

deep brain
8
brain stimulator
8
stimulator placement
8
generalized dystonia
8
dexmedetomidine deep
4
placement child
4
child primary
4
primary generalized
4
dystonia case
4
case report
4

Similar Publications

Objective: Pharmacoresistant tremors, often seen in Parkinson disease and essential tremor, significantly impair patient quality of life. Although deep brain stimulation has been effective, its invasive nature limits its applicability. MR-guided focused ultrasound (MRgFUS) thalamotomy offers a noninvasive alternative, but its cognitive impacts are not fully understood.

View Article and Find Full Text PDF

As the primary innate immune cells of the brain, microglia play a key role in various homeostatic and disease-related processes. To carry out their numerous functions, microglia adopt a wide range of phenotypic states. The proteomic landscape represents a more accurate molecular representation of these phenotypes; however, microglia present unique challenges for proteomic analysis.

View Article and Find Full Text PDF

Objectives: We evaluated the noise reduction effects of deep learning reconstruction (DLR) and hybrid iterative reconstruction (HIR) in brain computed tomography (CT).

Methods: CT images of a 16 cm dosimetry phantom, a head phantom, and the brains of 11 patients were reconstructed using filtered backprojection (FBP) and various levels of DLR and HIR. The slice thickness was 5, 2.

View Article and Find Full Text PDF

Deep Learning-Based Diagnosis Algorithm for Alzheimer's Disease.

J Imaging

December 2024

College of Electrical and Information, Northeast Agricultural University, 600 Changjiang Road, Harbin 150038, China.

Alzheimer's disease (AD), a degenerative condition affecting the central nervous system, has witnessed a notable rise in prevalence along with the increasing aging population. In recent years, the integration of cutting-edge medical imaging technologies with forefront theories in artificial intelligence has dramatically enhanced the efficiency of identifying and diagnosing brain diseases such as AD. This paper presents an innovative two-stage automatic auxiliary diagnosis algorithm for AD, based on an improved 3D DenseNet segmentation model and an improved MobileNetV3 classification model applied to brain MR images.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!